Bericht: Pfizer plant Verkauf von 4,55 Millionen Biontech-Aktien. Das Mainzer Unternehmen betont, die Kooperation mit Pfizer bleibe unverändert.

Paukenschläge bei Biotechs: Partner Pfizer verkauft seine komplette Beteiligung am deutschen Biotech-Champion BioNTech.

Während der Corona-Pandemie wird vielen Menschen in Deutschland bewusst, wie eng die Unternehmen Pfizer und Biontech miteinander verbandelt sind. Jetzt will der US-Konzern angeblich seine Anteile an d ...

The financial markets responded immediately, with BioNTech shares declining as much as 5% in pre-market trading. This partnership has historically formed the cornerstone of BioNTech's commercial ...

^MAINZ, Deutschland, 28. Oktober 2025 (GLOBE NEWSWIRE) -- BioNTech SE (https://www.biontech.com/de/de/home.html) (Nasdaq: BNTX, ?BioNTech" oder ?das Unternehmen") veranstaltet am Donnerstag, 11. Nove ...

When BioNTech agreed to acquire rival messenger RNA company CureVac in a $1.25 billion stock deal earlier this summer, some financial analysts said the buyout amounted to an out-of-court settlement of ...

Der Ausstieg von Pfizer aus Biontech wirft Fragen auf und schickt die Aktie der Mainzer auf Talfahrt. Analysten sehen in dem ...

We recently published 11 Best Cancer Stocks to Buy Right Now. BioNTech SE is one of them. BioNTech SE (NASDAQ:BNTX), a German biotechnology company, specializes in mRNA-based immunotherapies for ...

The biotech continues to embrace artificial intelligence (AI) technology, which is heartening for investors. It owns and manages an AI developer, InstaDeep. The company's push deeper into a hot new ...

BioNTech's first late-stage cancer trial success Phase III trial shows BNT323 slows HER2-positive breast cancer progression, companies say Companies compete with AstraZeneca-Daiichi alliance For COVID ...

BioNTech’s HER2 antibody-drug conjugate has beaten Roche’s Kadcyla in a phase 3 breast cancer trial, positioning the company’s partner Duality Biologics to seek approval for the candidate in China.